Erythropoietin Safety and Efficacy in Chronic Allograft Nephropathy

Transplantation Proceedings

Volumn 39, Issue 7, 2007, Pages 2245-2247

  Baltar, J ^a   Moran, N ^a   Ortega, F ^a   Ortega, T ^a   Rebollo, P ^a   Cofan, F ^a   Campistol, J M ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BLOOD PRESSURE; CADAVER; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEMATOCRIT; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANEMIA; BLOOD PRESSURE; CADAVER; CHRONIC DISEASE; CREATININE; ERYTHROPOIETIN; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SAFETY; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548680972     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.06.020     Document Type: Article

References (6)

1. European Best Practice Guidelines II Working Group. Revised European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 19 suppl 2 (2004) 111
2. Rossert J., Fouqueray B., and Boffa J.J. Anemia management and the delay of chronic renal failure progression. J Am Soc Nephrol 14 suppl 2 (2003) S173
3. Choukroun G., and Martinez F. Benefits of erythropoietin in renal transplantation. Transplantation 79 suppl 3 (2005) S49
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1
5. Lopez-Gomez J.M., Perez-Flores I., Jofre R., et al. Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance. J Am Soc Nephrol 15 (2004) 2494
6. Phrommintikul A., Haas S.J., Maros E., et al. Mortality and target hemoglobin concentrations in anemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369 (2007) 381